ARRANON Side Effects

7005652-8 | Epistaxis, Hypoaesthesia, Illusion, Pancytopenia, Paraesthesia, Restlessness, Tremor
on Sep 13, 2010 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with neoplasm malignant and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, hypoaesthesia, illusion, pancytopenia, paraesthesia, restlessness, tremor. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), CYTARABINE (100mgm2 Per Day) (View Cytarabine Review and Cytarabine Label ), PREDONINE (View Predonine Review and Predonine Label ), DECADRON (View Decadron Review and Decadron Label ).

6978703-4 | Abnormal Behaviour, Anger, Crying, Dysarthria, Eyelid Ptosis, Feeling Abnormal, Headache, Mood Altered, Nystagmus
Patient was taking Arranon (View Usage). Patient had the following side effects: abnormal behaviour, anger, crying, dysarthria, eyelid ptosis, feeling abnormal, headache (What is headache?), mood altered, nystagmus on Sep 02, 2010 from JAPAN Additional patient health information: Male patient , weighting 31.31 lb, was diagnosed with neoplasm malignant, fluid replacement, prophylaxis, hepaplastin test and. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), SOLDEM 3A (View Soldem 3a Review and Soldem 3a Label ), MEYLON (View Meylon Review and Meylon Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), KAYTWO N (View Kaytwo N Review and Kaytwo N Label ). Patient was hospitalized.

6963431-1 | Acute Respiratory Distress Syndrome, Anal Fissure, Cystitis Viral, Renal Disorder
Adverse event was reported on Aug 23, 2010 by a Male patient taking Arranon (View Usage) (Dosage: 1500mgm2 Per Day) was diagnosed with neoplasm malignant and. Location: JAPAN , weighting 121.3 lb, After Arranon was administered, patient had the following side effects: acute respiratory distress syndrome, anal fissure, cystitis viral, renal disorder. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), LEUNASE (View Leunase Review and Leunase Label ), VEPESID (130mg Per Day) (View Vepesid Review and Vepesid Label ).

6867193-8 | Epistaxis, Illusion, Pancytopenia, Restlessness
on Jul 16, 2010 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with neoplasm malignant and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, illusion, pancytopenia, restlessness. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (100mgm2 Per Day) (View Cytarabine Review and Cytarabine Label ), PREDONINE (View Predonine Review and Predonine Label ), DECADRON (View Decadron Review and Decadron Label ).


6844214-X | Hepatic Failure, Melaena, Oxygen Saturation Decreased, Pleural Effusion
on Jul 08, 2010 Female patient from JAPAN , weighting 121.3 lb, was diagnosed with neoplasm malignant, antiemetic supportive care and was treated with Arranon (View Usage). Patient had the following side effects: hepatic failure, melaena, oxygen saturation decreased, pleural effusion. Arranon dosage: 1000mgm2 Per Day. During the same period patient was treated with ADRIACIN (View Adriacin Review and Adriacin Label ), PREDONINE (View Predonine Review and Predonine Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ).

6820078-5 | Illusion, Pancytopenia, Restlessness
Patient was taking Arranon (View Usage). After Arranon was administered, patient had the following side effects: illusion, pancytopenia, restlessness on Jun 30, 2010 from JAPAN Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with neoplasm malignant and. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), CYTARABINE (100mgm2 Per Day) (View Cytarabine Review and Cytarabine Label ), PREDONINE (View Predonine Review and Predonine Label ), DECADRON (View Decadron Review and Decadron Label ).

6769962-1 | Hepatic Failure, Melaena, Oxygen Saturation Decreased, Pleural Effusion
Adverse event was reported on Jun 08, 2010 by a Female patient taking Arranon (View Usage) (Dosage: 1000mgm2 Per Day) was diagnosed with neoplasm malignant, antiemetic supportive care and. Location: JAPAN , weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: hepatic failure, melaena, oxygen saturation decreased, pleural effusion. During the same period patient was treated with ADRIACIN (View Adriacin Review and Adriacin Label ), PREDONINE (View Predonine Review and Predonine Label ), GRANISETRON (View Granisetron Review and Granisetron Label ).

6758514-5 | Acute Respiratory Distress Syndrome, Anal Fissure, Renal Disorder
on May 25, 2010 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Arranon (View Usage). Patient had the following side effects: acute respiratory distress syndrome, anal fissure, renal disorder. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), LEUNASE (View Leunase Review and Leunase Label ), VEPESID (130mg Per Day) (View Vepesid Review and Vepesid Label ).

6661193-9 | Acute Respiratory Distress Syndrome, Anal Fissure, Hypoaesthesia, Renal Disorder
on Mar 25, 2010 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: acute respiratory distress syndrome, anal fissure, hypoaesthesia, renal disorder. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), DAUNOMYCIN (View Daunomycin Review and Daunomycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), LEUNASE (View Leunase Review and Leunase Label ), VEPESID (130mg Per Day) (View Vepesid Review and Vepesid Label ).

6656058-2 | Blood Creatine Phosphokinase Increased, Malaise, Pain In Extremity, Rhabdomyolysis
Patient was taking Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, malaise, pain in extremity, rhabdomyolysis on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 31 years of age, weighting 229.5 lb, . Arranon dosage: 1500mgm2 Alternate Days. During the same period patient was treated with ALLOPURINOL (300g Per Day) (View Allopurinol Review and Allopurinol Label ), DECADRON (8mg Per Day) (View Decadron Review and Decadron Label ), OMEPRAZOLE (40g Per Day) (View Omeprazole Review and Omeprazole Label ), TYLENOL 500 (650g As Required) (View Tylenol-500 Review and Tylenol-500 Label ), ONDANSETRON (16g Per Day) (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6618399-4 | Abnormal Behaviour, Anger, Crying, Dysarthria, Eyelid Ptosis, Feeling Abnormal, Headache, Mood Altered, Nystagmus
Adverse event was reported on Feb 25, 2010 by a Male patient taking Arranon (View Usage) (Dosage: 650mgm2 Per Day) was diagnosed with neoplasm malignant, fluid replacement, prophylaxis, hepaplastin test and. Location: JAPAN , weighting 31.31 lb, Patient had the following side effects: abnormal behaviour, anger, crying, dysarthria, eyelid ptosis, feeling abnormal, headache (What is headache?), mood altered, nystagmus. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), SOLDEM 3A (View Soldem 3a Review and Soldem 3a Label ), MEYLON (View Meylon Review and Meylon Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), KAYTWO N (View Kaytwo N Review and Kaytwo N Label ). Patient was hospitalized.

6600191-8 | Restlessness
on Feb 16, 2010 Male patient from JAPAN , weighting 31.31 lb, was diagnosed with precursor t-lymphoblastic lymphoma/leukaemia, neoplasm malignant, fluid replacement, prophylaxis, hepaplastin test and was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: restlessness. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), SOLDEM 3A (View Soldem 3a Review and Soldem 3a Label ), MEYLON (View Meylon Review and Meylon Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), KAYTWO N (View Kaytwo N Review and Kaytwo N Label ). Patient was hospitalized.

6581490-5 | Restlessness
on Feb 03, 2010 Male patient from JAPAN , weighting 31.31 lb, was diagnosed with neoplasm malignant, fluid replacement, prophylaxis, hepaplastin test and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: restlessness. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), SOLDEM 3A (View Soldem 3a Review and Soldem 3a Label ), MEYLON (View Meylon Review and Meylon Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), KAYTWO N (View Kaytwo N Review and Kaytwo N Label ). Patient was hospitalized.

6581476-0 | Osmotic Demyelination Syndrome
Patient was taking Arranon (View Usage). Patient had the following side effects: osmotic demyelination syndrome on Feb 04, 2010 from JAPAN Additional patient health information: Female patient , weighting 112.4 lb, . Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), TEICOPLANIN (400mg Per Day) (View Teicoplanin Review and Teicoplanin Label ), ERYTHROCIN LACTOBIONATE (1500mg Per Day) (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), AMIKACIN SULFATE (400mg Per Day) (View Amikacin Sulfate Review and Amikacin Sulfate Label ), SOL MELCORT (1000mg Per Day) (View Sol-melcort Review and Sol-melcort Label ), CLINDAMYCIN (1200mg Per Day) (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized and became disabled.

6578263-6 | Epstein-barr Virus Infection
Adverse event was reported on Feb 09, 2010 by a Male patient taking Arranon (View Usage) (Dosage: 1200mgm2 Cyclic) . Location: UNITED STATES , 70 years of age, After Arranon was administered, patient had the following side effects: epstein-barr virus infection. During the same period patient was treated with GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ). Patient was hospitalized and became disabled.

6573734-0 | Osmotic Demyelination Syndrome
on Jan 26, 2010 Female patient from JAPAN , weighting 112.4 lb, was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: osmotic demyelination syndrome. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), MEROPEN (View Meropen Review and Meropen Label ), TEICOPLANIN (400mg Per Day) (View Teicoplanin Review and Teicoplanin Label ), ERYTHROCIN LACTOBIONATE (1500mg Per Day) (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), AMIKACIN SULFATE (400mg Per Day) (View Amikacin Sulfate Review and Amikacin Sulfate Label ), SOL MELCORT (1000mg Per Day) (View Sol-melcort Review and Sol-melcort Label ), CLINDAMYCIN (1200mg Per Day) (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized and became disabled.

6565135-6 | Altered State Of Consciousness, Arrhythmia, Bone Marrow Failure, Disorientation, Haematocrit Decreased, Haemoglobin Decreased, Hypotension, Platelet Count Decreased, Productive Cough
on Jan 25, 2010 Male patient from JAPAN , weighting 97.00 lb, was diagnosed with pneumonia (What is pneumonia?), enteritis infectious, disseminated intravascular coagulation and was treated with Arranon (View Usage). Patient had the following side effects: altered state of consciousness, arrhythmia (What is arrhythmia?), bone marrow failure, disorientation, haematocrit decreased, haemoglobin decreased, hypotension, platelet count decreased, productive cough. Arranon dosage: . During the same period patient was treated with PENTCILLIN (4g Per Day) (View Pentcillin Review and Pentcillin Label ), ITRIZOLE (200mg Per Day) (View Itrizole Review and Itrizole Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), TARGOCID (400mg Per Day) (View Targocid Review and Targocid Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), CRAVIT (400mg Per Day) (View Cravit Review and Cravit Label ), TAZOCIN (5g Per Day) (View Tazocin Review and Tazocin Label ).

6408796-4 | Altered State Of Consciousness, Arrhythmia, Bone Marrow Failure, Disorientation, Haematocrit Decreased, Haemoglobin Decreased, Hypotension, Platelet Count Decreased, Productive Cough
Patient was taking Arranon (View Usage). After Arranon was administered, patient had the following side effects: altered state of consciousness, arrhythmia (What is arrhythmia?), bone marrow failure, disorientation, haematocrit decreased, haemoglobin decreased, hypotension, platelet count decreased, productive cough on Oct 16, 2009 from JAPAN Additional patient health information: Male patient , weighting 97.00 lb, was diagnosed with pneumonia (What is pneumonia?), enteritis infectious, disseminated intravascular coagulation and. Arranon dosage: 1500mgk Per Day. During the same period patient was treated with PENTCILLIN (4g Per Day) (View Pentcillin Review and Pentcillin Label ), ITRIZOLE (200mg Per Day) (View Itrizole Review and Itrizole Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), TARGOCID (400mg Per Day) (View Targocid Review and Targocid Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), CRAVIT (400mg Per Day) (View Cravit Review and Cravit Label ), TAZOCIN (5g Per Day) (View Tazocin Review and Tazocin Label ).

6395321-X | White Blood Cell Count Decreased, White Blood Cell Count Increased
Adverse event was reported on Oct 02, 2009 by a Male patient taking Arranon (View Usage) (Dosage: ) was diagnosed with neoplasm malignant, antifungal prophylaxis and. Location: JAPAN , weighting 46.85 lb, Patient experienced the following unwanted or unexpected effects: white blood cell count decreased, white blood cell count increased. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), BACTRAMIN (View Bactramin Review and Bactramin Label ). Patient was hospitalized.

6395316-6 | Acute Hepatic Failure, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cardio-respiratory Arrest, Disseminated Intravascular Coagulation, Loss Of Consciousness
on Oct 05, 2009 Male patient from JAPAN , 27 years of age, weighting 138.9 lb, was treated with Arranon (View Usage). Patient had the following side effects: acute hepatic failure, alanine aminotransferase increased, aspartate aminotransferase increased, cardio-respiratory arrest, disseminated intravascular coagulation, loss of consciousness. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with KYTRIL (3mg Per Day) (View Kytril Review and Kytril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), REMINARON (2000mg Per Day) (View Reminaron Review and Reminaron Label ), CALCICOL (10ml Per Day) (View Calcicol Review and Calcicol Label ), PRIMPERAN (10mg Per Day) (View Primperan Review and Primperan Label ), OXYCONTIN (5mg Per Day) (View Oxycontin Review and Oxycontin Label ), NOVAMIN (10mg Per Day) (View Novamin Review and Novamin Label ). Patient was hospitalized.

6335082-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Febrile Neutropenia, Haemoglobin Decreased, Headache, Neutrophil Count Decreased, Oropharyngeal Pain, Pharyngitis
on Aug 25, 2009 Male patient from JAPAN , weighting 35.27 lb, was diagnosed with mycosis fungoides, neoplasm malignant and was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, febrile neutropenia, haemoglobin decreased, headache (What is headache?), neutrophil count decreased, oropharyngeal pain, pharyngitis. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ).

6331062-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Febrile Neutropenia, Haemoglobin Decreased, Headache, Neutrophil Count Decreased, Oropharyngeal Pain, Pharyngitis
Patient was taking Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, febrile neutropenia, haemoglobin decreased, headache (What is headache?), neutrophil count decreased, oropharyngeal pain, pharyngitis on Aug 18, 2009 from JAPAN Additional patient health information: Male patient , weighting 35.27 lb, was diagnosed with mycosis fungoides, neoplasm malignant and. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with CYLOCIDE (View Cylocide Review and Cylocide Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ).

6327149-0 | Acute Hepatic Failure, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cardio-respiratory Arrest, Disseminated Intravascular Coagulation, Loss Of Consciousness
Adverse event was reported on Aug 20, 2009 by a Male patient taking Arranon (View Usage) (Dosage: 1500mgm2 Per Day) . Location: JAPAN , 27 years of age, weighting 138.9 lb, Patient had the following side effects: acute hepatic failure, alanine aminotransferase increased, aspartate aminotransferase increased, cardio-respiratory arrest, disseminated intravascular coagulation, loss of consciousness. During the same period patient was treated with KYTRIL (3mg Per Day) (View Kytril Review and Kytril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), REMINARON (2000mg Per Day) (View Reminaron Review and Reminaron Label ), CALCICOL (10ml Per Day) (View Calcicol Review and Calcicol Label ), PRIMPERAN (10mg Per Day) (View Primperan Review and Primperan Label ), OXYCONTIN (5mg Per Day) (View Oxycontin Review and Oxycontin Label ), NOVAMIN (10mg Per Day) (View Novamin Review and Novamin Label ). Patient was hospitalized.

6249488-4 | Renal Impairment
on Jun 17, 2009 Male patient from JAPAN , weighting 154.3 lb, was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: renal impairment. Arranon dosage: 1500mgm2 Alternate Days. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), GRAN (View Gran Review and Gran Label ), FUNGUARD (View Funguard Review and Funguard Label ), VFEND (400mg Per Day) (View Vfend Review and Vfend Label ), CEFTAZIDIME (4g Per Day) (View Ceftazidime Review and Ceftazidime Label ), VANCOMYCIN (2g Per Day) (View Vancomycin Review and Vancomycin Label ), PASIL (1000mg Per Day) (View Pasil Review and Pasil Label ), TAKEPRON (View Takepron Review and Takepron Label ).

6231511-4 | Faeces Discoloured, Gastrointestinal Haemorrhage, Hepatic Steatosis
on Jun 09, 2009 Male patient from JAPAN , weighting 58.20 lb, was diagnosed with neoplasm malignant and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: faeces discoloured, gastrointestinal haemorrhage, hepatic steatosis. Arranon dosage: 325mg Per Day. During the same period patient was treated with ELSPAR (View Elspar Review and Elspar Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FILDESIN (View Fildesin Review and Fildesin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), FLUCONAL (View Fluconal Review and Fluconal Label ), PREDONINE (View Predonine Review and Predonine Label ).

6199557-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Eosinophil Count Increased, Hepatic Function Abnormal, Somnolence
Patient was taking Arranon (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, eosinophil count increased, hepatic function abnormal, somnolence on May 11, 2009 from JAPAN Additional patient health information: Male patient , 41 years of age, weighting 156.5 lb, was diagnosed with neoplasm malignant, infection prophylaxis, constipation prophylaxis, asthma (What is asthma?) and. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MAGLAX (View Maglax Review and Maglax Label ), SINGULAIR (View Singulair Review and Singulair Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), ZANTAC (View Zantac Review and Zantac Label ), ALOSITOL (View Alositol Review and Alositol Label ).

6190377-1 | Renal Impairment
Adverse event was reported on May 07, 2009 by a Male patient taking Arranon (View Usage) (Dosage: 1500mgm2 Alternate Days) . Location: JAPAN , weighting 154.3 lb, After Arranon was administered, patient had the following side effects: renal impairment. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), GRAN (View Gran Review and Gran Label ), FUNGUARD (View Funguard Review and Funguard Label ), VFEND (400mg Per Day) (View Vfend Review and Vfend Label ), CEFTAZIDIME (4g Per Day) (View Ceftazidime Review and Ceftazidime Label ), VANCOMYCIN HCL (2g Per Day) (View Vancomycin Hcl Review and Vancomycin Hcl Label ), PASIL (1000mg Per Day) (View Pasil Review and Pasil Label ), TAKEPRON (View Takepron Review and Takepron Label ).

6132162-2 | White Blood Cell Count Increased
on Mar 19, 2009 Male patient from JAPAN , child 5 years of age, weighting 46.85 lb, was diagnosed with neoplasm malignant, antifungal prophylaxis and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count increased. Arranon dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), MITOXANTRONE HYDROCHLORIDE (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6126164-X | Alanine Aminotransferase Increased, Anaemia, Febrile Neutropenia, Hyperbilirubinaemia, Hypoaesthesia, Muscular Weakness, Platelet Count Decreased, Stomatitis
on Mar 17, 2009 Male patient from JAPAN , 19 years of age, weighting 110.2 lb, was diagnosed with neoplasm malignant and was treated with Arranon (View Usage). Patient had the following side effects: alanine aminotransferase increased, anaemia, febrile neutropenia, hyperbilirubinaemia, hypoaesthesia, muscular weakness, platelet count decreased, stomatitis. Arranon dosage: 1500mg Per Day. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (807mg Per Day) (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ), ETOPOSIDE (110mg Per Day) (View Etoposide Review and Etoposide Label ), CYTARABINE (110mg Per Day) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), ONCOVIN (View Oncovin Review and Oncovin Label ). Patient was hospitalized and became disabled.

6122849-X | Aldolase Increased, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
Patient was taking Arranon (View Usage). After Arranon was administered, patient had the following side effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis on Mar 12, 2009 from JAPAN Additional patient health information: Male patient , child 2 years of age, weighting 27.34 lb, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm, neoplasm malignant and. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with ZYLORIC (99mg Per Day) (View Zyloric Review and Zyloric Label ), BAKTAR (.6g Per Day) (View Baktar Review and Baktar Label ), HYDROCORTISONE 10MG TAB (20mg Per Day) (View Hydrocortisone 10mg Tab Review and Hydrocortisone 10mg Tab Label ), CYLOCIDE (25mg Per Day) (View Cylocide Review and Cylocide Label ), NEO MINOPHAGEN C (20mg Per Day) (View Neo-minophagen-c Review and Neo-minophagen-c Label ), ZOFRAN (View Zofran Review and Zofran Label ), FLUDARA (View Fludara Review and Fludara Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ).

6122848-8 | Liver Disorder
Adverse event was reported on Mar 13, 2009 by a Male patient taking Arranon (View Usage) (Dosage: 1500mgm2 Per Day) was diagnosed with infection prophylaxis, gastrointestinal ulcer and. Location: JAPAN , 27 years of age, weighting 101.4 lb, Patient experienced the following unwanted or unexpected effects: liver disorder. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), FLUCONAZOLE (10mg Per Day) (View Fluconazole Review and Fluconazole Label ), PARIET (10mg Per Day) (View Pariet Review and Pariet Label ), SALOBEL (View Salobel Review and Salobel Label ).

6122847-6 | Mobility Decreased, Vertigo
on Mar 13, 2009 Male patient from JAPAN , 38 years of age, weighting 127.9 lb, was diagnosed with t-cell type acute leukaemia, prophylaxis of nausea and vomiting and was treated with Arranon (View Usage). Patient had the following side effects: mobility decreased, vertigo. Arranon dosage: 2600mg Per Day. During the same period patient was treated with KYTRIL (3mg Twice Per Day) (View Kytril Review and Kytril Label ), SEISHOKU (View Seishoku Review and Seishoku Label ), MEYLON (View Meylon Review and Meylon Label ), DEXTROSE 5% (View Dextrose 5% Review and Dextrose 5% Label ), TAKEPRON (30mg Per Day) (View Takepron Review and Takepron Label ), MAGMITT (330mg Three Times Per Day) (View Magmitt Review and Magmitt Label ), ITRIZOLE (100mg Twice Per Day) (View Itrizole Review and Itrizole Label ).

6109401-7 | Memory Impairment
on Mar 06, 2009 Male patient from JAPAN , 68 years of age, weighting 165.3 lb, was diagnosed with infection prophylaxis, gastritis and was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: memory impairment. Arranon dosage: 1500mgm2 Cyclic. During the same period patient was treated with MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), KYTRIL (View Kytril Review and Kytril Label ), BAKTAR (View Baktar Review and Baktar Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), GASTER (View Gaster Review and Gaster Label ).

6107762-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Eosinophil Count Increased, Hepatic Function Abnormal, Somnolence
Patient was taking Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, eosinophil count increased, hepatic function abnormal, somnolence on Mar 02, 2009 from JAPAN Additional patient health information: Male patient , 41 years of age, weighting 156.5 lb, was diagnosed with neoplasm malignant, infection prophylaxis, constipation prophylaxis, asthma (What is asthma?) and. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MAGLAX (View Maglax Review and Maglax Label ), SINGULAIR (View Singulair Review and Singulair Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), ZANTAC (View Zantac Review and Zantac Label ), ALOSITOL (View Alositol Review and Alositol Label ).

6098861-6 | Alanine Aminotransferase Increased, Blood Bilirubin Increased, Eosinophil Count Increased, Hepatic Function Abnormal, Somnolence
Adverse event was reported on Feb 27, 2009 by a Male patient taking Arranon (View Usage) (Dosage: 1500mgm2 Per Day) was diagnosed with neoplasm malignant, infection prophylaxis, constipation prophylaxis, asthma (What is asthma?) and. Location: JAPAN , 41 years of age, weighting 156.5 lb, Patient had the following side effects: alanine aminotransferase increased, blood bilirubin increased, eosinophil count increased, hepatic function abnormal, somnolence. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MAGLAX (View Maglax Review and Maglax Label ), SINGULAIR (View Singulair Review and Singulair Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), ZANTAC (View Zantac Review and Zantac Label ), ALOSITOL (View Alositol Review and Alositol Label ).

6097312-5 | Rash, Urticaria
on Jan 08, 2009 Male patient from UNITED STATES , child 4 years of age, was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: rash (What is rash?), urticaria. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ).

6085843-3 | Aldolase Increased, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
on Feb 16, 2009 Male patient from JAPAN , child 2 years of age, weighting 27.34 lb, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm, neoplasm malignant and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with ZYLORIC (99mg Per Day) (View Zyloric Review and Zyloric Label ), BAKTAR (.6g Per Day) (View Baktar Review and Baktar Label ), HYDROCORTISONE 10MG TAB (20mg Per Day) (View Hydrocortisone 10mg Tab Review and Hydrocortisone 10mg Tab Label ), CYLOCIDE (25mg Per Day) (View Cylocide Review and Cylocide Label ), NEO MINOPHAGEN C (20mg Per Day) (View Neo-minophagen-c Review and Neo-minophagen-c Label ), ZOFRAN (View Zofran Review and Zofran Label ), FLUDARA (View Fludara Review and Fludara Label ).

6074096-8 | Memory Impairment
Patient was taking Arranon (View Usage). Patient had the following side effects: memory impairment on Feb 06, 2009 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 165.3 lb, was diagnosed with infection prophylaxis, gastritis and. Arranon dosage: 1500mgm2 Cyclic. During the same period patient was treated with MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), KYTRIL (View Kytril Review and Kytril Label ), BAKTAR (View Baktar Review and Baktar Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), GASTER (View Gaster Review and Gaster Label ).

6071001-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder
Adverse event was reported on Feb 06, 2009 by a Male patient taking Arranon (View Usage) (Dosage: 2500mg Per Day) . Location: JAPAN , 38 years of age, weighting 130.1 lb, After Arranon was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), CRAVIT (View Cravit Review and Cravit Label ), GASTER (View Gaster Review and Gaster Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), ENTOMOL (View Entomol Review and Entomol Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ).

6070998-7 | Altered State Of Consciousness, Arrhythmia, Bone Marrow Failure, Disorientation, Haematocrit Decreased, Haemoglobin Decreased, Hypotension, Platelet Count Decreased, Productive Cough
on Feb 05, 2009 Male patient from JAPAN , 63 years of age, weighting 97.00 lb, was diagnosed with pneumonia (What is pneumonia?), disseminated intravascular coagulation and was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, arrhythmia (What is arrhythmia?), bone marrow failure, disorientation, haematocrit decreased, haemoglobin decreased, hypotension, platelet count decreased, productive cough. Arranon dosage: 1500mgk Per Day. During the same period patient was treated with PENTCILLIN (4g Per Day) (View Pentcillin Review and Pentcillin Label ), ITRIZOLE (200mg Per Day) (View Itrizole Review and Itrizole Label ), MAXIPIME (4g Per Day) (View Maxipime Review and Maxipime Label ), TARGOCID (400mg Per Day) (View Targocid Review and Targocid Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ), CRAVIT (400mg Per Day) (View Cravit Review and Cravit Label ), TAZOCIN (5g Per Day) (View Tazocin Review and Tazocin Label ).

6044087-1 | Aldolase Increased, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
on Jan 08, 2009 Male patient from JAPAN , child 2 years of age, weighting 27.34 lb, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm, neoplasm malignant and was treated with Arranon (View Usage). Patient had the following side effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis. Arranon dosage: 650mgm2 Per Day. During the same period patient was treated with ZYLORIC (99mg Per Day) (View Zyloric Review and Zyloric Label ), COTRIM (.6g Per Day) (View Cotrim Review and Cotrim Label ), HYDROCORTISONE 10MG TAB (20mg Per Day) (View Hydrocortisone 10mg Tab Review and Hydrocortisone 10mg Tab Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), NEO MINOPHAGEN C (20mg Per Day) (View Neo-minophagen-c Review and Neo-minophagen-c Label ), ZOFRAN (View Zofran Review and Zofran Label ), FLUDARA (View Fludara Review and Fludara Label ).

5972519-3 | Bone Marrow Tumour Cell Infiltration, Thrombocytopenia
Patient was taking Arranon (View Usage). After Arranon was administered, patient had the following side effects: bone marrow tumour cell infiltration, thrombocytopenia on Nov 28, 2008 from JAPAN Additional patient health information: Female patient , 23 years of age, weighting 136.7 lb, was diagnosed with neoplasm malignant, prophylaxis of nausea and vomiting, infection prophylaxis and. Arranon dosage: 1500mgm2 Per Day. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NASEA (View Nasea Review and Nasea Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), TAKEPRON (View Takepron Review and Takepron Label ), COTRIM (View Cotrim Review and Cotrim Label ).

5965744-9 | Liver Disorder
Adverse event was reported on Nov 21, 2008 by a Male patient taking Arranon (View Usage) (Dosage: 2175mg Per Day) was diagnosed with infection prophylaxis, gastrointestinal ulcer and. Location: JAPAN , 27 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), FLUCONAZOLE (10mg Per Day) (View Fluconazole Review and Fluconazole Label ), RABEPRAZOLE SODIUM (10mg Per Day) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

5961042-8 | Ill-defined Disorder, Pain In Extremity, Rash
on Sep 23, 2008 Female patient from UNITED STATES , child 3 years of age, was treated with Arranon (View Usage). Patient had the following side effects: ill-defined disorder, pain in extremity, rash (What is rash?). Arranon dosage: .

5961041-6 | Hypoaesthesia, Neuropathy Peripheral
on Aug 15, 2008 Female patient from UNITED STATES , 42 years of age, was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: hypoaesthesia, neuropathy peripheral. Arranon dosage: 1500mgm2 Variable Dose. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

5958085-7 | Aldolase Increased, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
Patient was taking Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis on Nov 14, 2008 from JAPAN Additional patient health information: Male patient , child 2 years of age, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm and. Arranon dosage: 70ml Per Day. During the same period patient was treated with ZYLORIC (99mg Per Day) (View Zyloric Review and Zyloric Label ), COTRIM (.6g Per Day) (View Cotrim Review and Cotrim Label ), HYDROCORTISONE 10MG TAB (20mg Per Day) (View Hydrocortisone 10mg Tab Review and Hydrocortisone 10mg Tab Label ), CYLOCIDE (25mg Per Day) (View Cylocide Review and Cylocide Label ), NEO MINOPHAGEN C (20mg Per Day) (View Neo-minophagen-c Review and Neo-minophagen-c Label ), FUNGUARD (50mg Per Day) (View Funguard Review and Funguard Label ).

5948502-0 | Rhabdomyolysis
Adverse event was reported on Nov 06, 2008 by a Male patient taking Arranon (View Usage) (Dosage: 350mg Per Day) . Location: JAPAN , child 2 years of age, Patient had the following side effects: rhabdomyolysis. During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), COTRIM (View Cotrim Review and Cotrim Label ), HYDROCORTISONE 10MG TAB (View Hydrocortisone 10mg Tab Review and Hydrocortisone 10mg Tab Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ), NEO MINOPHAGEN C (View Neo-minophagen-c Review and Neo-minophagen-c Label ), FUNGUARD (View Funguard Review and Funguard Label ).

5946530-2 | Liver Function Test Abnormal
on Oct 31, 2008 Male patient from JAPAN , 27 years of age, was treated with Arranon (View Usage). After Arranon was administered, patient had the following side effects: liver function test abnormal. Arranon dosage: 2250mg Per Day. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ).

5913882-9 | Memory Impairment
on Oct 03, 2008 Male patient from JAPAN , 68 years of age, weighting 165.3 lb, was treated with Arranon (View Usage). Patient experienced the following unwanted or unexpected effects: memory impairment. Arranon dosage: 1500mgm2 Cyclic. During the same period patient was treated with MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYLOCIDE (View Cylocide Review and Cylocide Label ).

5913836-2 | Adverse Event, Eye Disorder, Eye Haemorrhage, Neutropenia, Ocular Cancer Metastatic, Pyrexia, Vision Blurred
Patient was taking Arranon (View Usage). Patient had the following side effects: adverse event, eye disorder, eye haemorrhage, neutropenia, ocular cancer metastatic, pyrexia, vision blurred on Oct 06, 2008 from UNITED STATES Additional patient health information: Male patient , 17 years of age, weighting 160.1 lb, . Arranon dosage: . Patient was hospitalized.